Meeting
2018 ASCO Annual Meeting
Beyond BRCA1 and BRCA2: Implementation of a multigene panel for the upfront testing of germline mutations in ovarian cancer.
Authors
Maria Beatriz Mira
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal
Maria Beatriz Mira , Isalia Margarida Campos Miguel , Sofia Fragoso , Ana Luís , Ana Clara , Sandra Bento , Ana Gaspar Opiniao , Patricia Machado , Sidonia Santos , Paula Rodrigues , Joana Parreira , Ana Francisca , Fatima H. Vaz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1542)
DOI
10.1200/JCO.2018.36.15_suppl.1542
Abstract #
1542
Poster Bd #
113
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer.
First Author: Li yuan Guo
Poster
2016 ASCO Annual Meeting
Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).
First Author: Philipp Harter
Poster
2020 ASCO Virtual Scientific Program
Value of multigene panel retesting of families with BRCA1/2 mutation-negative hereditary breast and ovarian cancer (HBOC).
First Author: Ekaterina Meshoulam Nikolaeva
Poster
2018 ASCO Annual Meeting
Impact of pre-surgical germline multigene panel testing on choice of surgery for breast cancer.
First Author: Elena Zarcaro